Skip to main content
. 2017 Oct 18;7(12):3955–3966. doi: 10.1534/g3.117.300284

Figure 1.

Figure 1

Kanamycin resistance of mutants. (A) Boxplots showing distributions of MICs of kanamycin of the wild type (WT) and various mutants. The number of replicates is mentioned over each boxplot. All mutants, except RpoDL261Q, CpxAF218Y, and CyaAN600Y, are significantly more resistant than the wild type (Welch two sample t-test, P < 10−7). Although the medians of the FusAA608E-RpoDL261Q/CpxAF218Y/TopAS180L/CyaAN600Y double mutants tend to be higher than that of the FusAP610T mutant, this difference is not statistically significant (P > 0.09). The difference between the medians of these double mutants and the FusAA608E mutant are statistically significant (P < 0.02), except in the case of the FusAA608E-TopAS180L mutant (P = 0.061) (B) Growth of mutants in 8-kan. (C) Growth of the RpoDL261Q, CpxAF218Y, and CyaAN600Y mutants in 1.5-kan. In (B) and (C), error bars represent SD of eight replicates. Some part of this data had been generated in our previous work (Mogre et al. 2014), with the inclusion of more replicates and data of single mutants.